Global law firm Greenberg Traurig, P.A. advised APx Acquisition Corp. I, a special purpose acquisition company, in its definitive business combination agreement with OmnigenicsAI Corp, a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd, a UK-based AI-enabled preventive medicine company.
MIAMI, March 27, 2024 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, P.A. advised APx Acquisition Corp. I, a special purpose acquisition company, in its definitive business combination agreement with OmnigenicsAI Corp, a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd, a UK-based AI-enabled preventive medicine company.
The strategic combination will create a global AI-driven genomics company with a significant presence in Latin America that will focus on providing secure, precise, and reliable biological data. The combined company currently operates primarily in Argentina, Mexico, Paraguay, and the UK, though it is expected to continue expanding its geographic footprint beyond Latin America, including into the United States.
Upon closing, OmnigenicsAI Corp will become the shareholder of APx and MultiplAI. The shares and warrants of OmnigenicsAI Corp will be listed on Nasdaq under the ticker symbols "OMNI" and "OMNIW," respectively. The transaction is expected to close mid-year and values OmnigenicsAI Corp and MultiplAI at a combined enterprise value of $340 million.
As planned, the combined company will offer a comprehensive suite of health evaluation services using AI. The integration of AI with precision medicine enables the interpretation of complex genomic data and allows for the delivery of highly personalized health insights, according to the company's press release.
"We are pleased to be assisting APx in its efforts to combine with OmnigenicsAI Corp and MultiplAI and to help create a global platform that integrates AI with precision medicine, particularly across Latin America. Greenberg Traurig has recently been more active than ever in helping companies in the Latin American region access U.S. capital markets as part of their growth strategy and liquidity management," said Antonio Peña, co-chair of the firm's Latin America Practice, Corporate Practice Co-Chair and SPAC Chair Alan I. Annex, and Corporate Shareholder Thomas R. Martin, in a joint statement.
APx is a publicly traded SPAC led by serial SPAC sponsor Kyle Bransfield in partnership with Daniel Braatz and Xavier Martinez of APx Capital. APx focuses its search on companies in Latin American countries or companies outside of Latin America that provide goods and services to Spanish-speaking markets.
The Greenberg Traurig team representing APx was led by Peña, Annex, and Miami Corporate Shareholders Martin and Arnaldo C. Rego, Jr.
Other shareholders included Miami Tax Shareholder L. Frank Cordero, New York Antitrust Shareholder Stephen M. Pepper, Northern Virginia and Denver Tax Shareholder Robert D. Simon, London Litigation Shareholder Gillian Sproul, Denver Data Privacy & Cybersecurity Shareholder Tyler J. Thompson, Miami Intellectual Property & Technology Shareholder Manuel R. Valcarcel IV, and London Corporate Shareholder and Chair of the London Mergers and Acquisitions team Henrietta Walker, as well as London Corporate Senior Associate Patrick G. Lilly, Orlando Associate Talia Boiangin, Miami Corporate Associates Anthony J. Fernandez, Sami B. Ghneim, Macy K. Nix, and Javier M. Sanchez.
About Greenberg Traurig's Corporate Practice: Greenberg Traurig's Corporate Practice comprises more than 600 lawyers in the United States, Europe, Asia, the Middle East and Latin America who regularly advise public and privately held companies, entrepreneurs and investment funds on global mergers and acquisitions, corporate restructurings, private equity and venture capital, underwritten and syndicated offerings, commercial finance and syndicated lending, cross-border transactions, and general corporate matters. The group's industry experience includes transactions in a wide range of fields, from the pharmaceutical, medical devices, and life sciences fields, to representations involving clients in the aviation, banking, consumer products, energy, food and beverage, health care, manufacturing, media, technology, and telecommunications sectors.
About Greenberg Traurig: Greenberg Traurig, LLP has more than 2750 attorneys in 47 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI "Highly Recommended Law Firm" for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA's Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.
Media Contact
Elaine Walker, Greenberg Traurig, P.A., +1 305.579.0832, [email protected], http://www.gtlaw.com/
SOURCE Greenberg Traurig, P.A.
Share this article